Glutamate-N-methyl-D-aspartate receptor modulation and minocycline for the treatment of patients with schizophrenia: an update
Cristiano Chaves(Queen's University), Jaime E. C. Hallak(Universidade de Ribeirão Preto), João Paulo Sousa(Universidade de Ribeirão Preto), Antônio Waldo Zuardi(Universidade de Ribeirão Preto), Serdar Dursun(University of Alberta), Clarissa Trzesniak(Conselho Nacional de Desenvolvimento Científico e Tecnológico), J.A.S. Crippa(National Council for Scientific and Technological Development), Cristiane Reberte de Marque(Universidade de Ribeirão Preto)
Cited by 75
Related Papers
Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology
|American Journal of Psychiatry|2016|1.1k
Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial
|Psychological Medicine|2018|819
Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naïve Social Phobia Patients
|Neuropsychopharmacology|2011|763
Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report
|Journal of Psychopharmacology|2010|530
Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report
|Brazilian Journal of Psychiatry|2015|484